Literature DB >> 17051603

Case-orientated approach to the management of hepatocellular adenoma.

D J van der Windt1, N F M Kok, S M Hussain, P E Zondervan, I P J Alwayn, R A de Man, J N M IJzermans.   

Abstract

BACKGROUND: Treatment of suspected hepatocellular adenoma (HA) remains controversial. The aim of this study was to evaluate the management of HA at a time when magnetic resonance imaging (MRI) and computed tomography (CT) are highly sensitive methods for diagnosing HA.
METHODS: Between January 2000 and January 2005, data from 48 consecutive women with HA (median age 36 years) were prospectively collected. The protocol for diagnostic work-up consisted of multiphasic MRI or CT. Management was observation if the tumour was smaller than 5 cm and surgical intervention if it was 5 cm or larger.
RESULTS: The median follow-up was 24 (range 3-73) months. Sixteen (33 per cent) patients had invasive procedures because of tumour size 5 cm or larger, malignant characteristics or haemorrhage. The remaining 32 patients (67 per cent) were observed; haemorrhage and malignant degeneration did not occur and none of the lesions showed enlargement after withdrawal of oral contraceptives. Multiple HAs were found in 32 (67 per cent) patients; liver steatosis was significantly more common in these patients than in those with a solitary lesion (59 versus 19 per cent; P = 0.008).
CONCLUSION: Observation of adenomas smaller than 5 cm is justified because of improved radiological reliability. Resection should be reserved for patients with malignant tumour characteristics or with single lesions 5 cm or larger.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051603     DOI: 10.1002/bjs.5511

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

1.  Hepatocellular adenoma: Should phenotypic classification direct management?

Authors:  Türkan Terkivatan; Jan N M Ijzermans
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 46.802

2.  Malignant transformation of hepatocellular adenoma: how frequently does it happen?

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

Review 3.  Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.

Authors:  Maarten G Thomeer; Mirelle E E Bröker; Quido de Lussanet; Katharina Biermann; Roy S Dwarkasing; Rob de Man; Jan N Ijzermans; Marianne de Vries
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

4.  Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI.

Authors:  Timm Denecke; Ingo G Steffen; Sheela Agarwal; Daniel Seehofer; Thomas Kröncke; Enrique Lopez Hänninen; Incken-Birthe Kramme; Peter Neuhaus; Sanjay Saini; Bernd Hamm; Christian Grieser
Journal:  Eur Radiol       Date:  2012-03-22       Impact factor: 5.315

5.  European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.

Authors:  Alexis Laurent; Safi Dokmak; Jean-Charles Nault; François-René Pruvot; Jean-Michel Fabre; Christian Letoublon; Philippe Bachellier; Lorenzo Capussotti; Olivier Farges; Jean-Yves Mabrut; Yves-Patrice Le Treut; Ahmet Ayav; Bertrand Suc; Olivier Soubrane; Gilles Mentha; Irinel Popescu; Marco Montorsi; Nicolas Demartines; Jacques Belghiti; Guido Torzilli; Daniel Cherqui; Jean Hardwigsen
Journal:  HPB (Oxford)       Date:  2016-07-22       Impact factor: 3.647

Review 6.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.

Authors:  Jan H M B Stoot; Robert J S Coelen; Mechteld C De Jong; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

7.  Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Satoshi Sekiguchi; Kazuyuki Ishida; Takehiko Igarashi; Yuta Wakui; Takao Iwasaki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Hepatocellular adenoma: what is new in 2008.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Christophe Laurent; Jessica Zucman-Rossi; Charles Balabaud
Journal:  Hepatol Int       Date:  2008-05-01       Impact factor: 6.047

Review 9.  Current Approaches in the Management of Hepatic Adenomas.

Authors:  Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452

10.  The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach.

Authors:  Mirelle E E Bröker; Jan N M Ijzermans; Susanna M van Aalten; Robert A de Man; Türkan Terkivatan
Journal:  Int J Hepatol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.